176 related articles for article (PubMed ID: 24324692)
1. T cells at the site of autoimmune inflammation show increased potential for trogocytosis.
Haastert B; Mellanby RJ; Anderton SM; O'Connor RA
PLoS One; 2013; 8(12):e81404. PubMed ID: 24324692
[TBL] [Abstract][Full Text] [Related]
2. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
[TBL] [Abstract][Full Text] [Related]
3. In vivo imaging of lymphocytes in the CNS reveals different behaviour of naïve T cells in health and autoimmunity.
Herz J; Paterka M; Niesner RA; Brandt AU; Siffrin V; Leuenberger T; Birkenstock J; Mossakowski A; Glumm R; Zipp F; Radbruch H
J Neuroinflammation; 2011 Oct; 8():131. PubMed ID: 21978405
[TBL] [Abstract][Full Text] [Related]
4. Cyclic AMP Pathway Suppress Autoimmune Neuroinflammation by Inhibiting Functions of Encephalitogenic CD4 T Cells and Enhancing M2 Macrophage Polarization at the Site of Inflammation.
Veremeyko T; Yung AWY; Dukhinova M; Kuznetsova IS; Pomytkin I; Lyundup A; Strekalova T; Barteneva NS; Ponomarev ED
Front Immunol; 2018; 9():50. PubMed ID: 29422898
[TBL] [Abstract][Full Text] [Related]
5. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
6. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
Sun JB; Czerkinsky C; Holmgren J
J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
[TBL] [Abstract][Full Text] [Related]
7. A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4
Wan X; Pei W; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
J Immunol; 2018 Aug; 201(4):1194-1210. PubMed ID: 29987163
[TBL] [Abstract][Full Text] [Related]
8. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of experimental autoimmune encephalomyelitis by the quinoline-3-carboxamide paquinimod: reduced priming of proinflammatory effector CD4(+) T cells.
Helmersson S; Sundstedt A; Deronic A; Leanderson T; Ivars F
Am J Pathol; 2013 May; 182(5):1671-80. PubMed ID: 23506849
[TBL] [Abstract][Full Text] [Related]
10. Depletion of CD4(+)CD25(+) T cells exacerbates experimental autoimmune encephalomyelitis induced by mouse, but not rat, antigens.
Akirav EM; Bergman CM; Hill M; Ruddle NH
J Neurosci Res; 2009 Nov; 87(15):3511-9. PubMed ID: 19125411
[TBL] [Abstract][Full Text] [Related]
11. Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response.
Bailey-Bucktrout SL; Martinez-Llordella M; Zhou X; Anthony B; Rosenthal W; Luche H; Fehling HJ; Bluestone JA
Immunity; 2013 Nov; 39(5):949-62. PubMed ID: 24238343
[TBL] [Abstract][Full Text] [Related]
12. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L
Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120
[TBL] [Abstract][Full Text] [Related]
13. Naive T lymphocytes traffic to inflamed central nervous system, but require antigen recognition for activation.
Krakowski ML; Owens T
Eur J Immunol; 2000 Apr; 30(4):1002-9. PubMed ID: 10760787
[TBL] [Abstract][Full Text] [Related]
14. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis.
Krakowski ML; Owens T
Eur J Immunol; 1997 Nov; 27(11):2840-7. PubMed ID: 9394808
[TBL] [Abstract][Full Text] [Related]
15. Treg and T-effector cells in autoimmune CNS inflammation: a delicate balance, easily disturbed.
Anderton SM
Eur J Immunol; 2010 Dec; 40(12):3321-4. PubMed ID: 21110316
[TBL] [Abstract][Full Text] [Related]
16. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
Zhou G; Ding ZC; Fu J; Levitsky HI
J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
[TBL] [Abstract][Full Text] [Related]
17. Capture of target cell membrane components via trogocytosis is triggered by a selected set of surface molecules on T or B cells.
Hudrisier D; Aucher A; Puaux AL; Bordier C; Joly E
J Immunol; 2007 Mar; 178(6):3637-47. PubMed ID: 17339461
[TBL] [Abstract][Full Text] [Related]
18. Transfer of cell membrane components via trogocytosis occurs in CD4+ Foxp3+ CD25+ regulatory T-cell contact-dependent suppression.
Bahcheli D; Hay V; Nadeau JL; Piccirillo CA
Autoimmunity; 2011 Dec; 44(8):607-15. PubMed ID: 21604971
[TBL] [Abstract][Full Text] [Related]
19. Antigen presentation between T cells drives Th17 polarization under conditions of limiting antigen.
Boccasavia VL; Bovolenta ER; Villanueva A; Borroto A; Oeste CL; van Santen HM; Prieto C; Alonso-López D; Diaz-Muñoz MD; Batista FD; Alarcón B
Cell Rep; 2021 Mar; 34(11):108861. PubMed ID: 33730591
[TBL] [Abstract][Full Text] [Related]
20. Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity.
Wu GF; Shindler KS; Allenspach EJ; Stephen TL; Thomas HL; Mikesell RJ; Cross AH; Laufer TM
J Autoimmun; 2011 Feb; 36(1):56-64. PubMed ID: 21095100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
